Firefly Neuroscience, Inc. is a Toronto-based medical technology and artificial intelligence firm focused on developing innovative neuroscientific solutions to enhance treatment outcomes for patients suffering from mental illnesses and neurological disorders. By leveraging advanced AI-driven analytics and cutting-edge research, the company aims to transform patient care and address unmet needs in the mental health sector. Firefly's commitment to pioneering advancements positions it strategically within a growing market, offering significant potential for institutional investors seeking exposure to breakthroughs in healthcare technology.